Latest News of RLMD
Institutional investors have a lot riding on Relmada Therapeutics, Inc. (NASDAQ:RLMD) with 48% ownership
By Yahoo! Finance |
2 months ago
Research on ownership and analyst forecasts data are crucial in understanding stock opportunities. Institutions hold a significant stake in Relmada Therapeutics, influencing its performance. Analysts ...